BLFS BIOLIFE SOLUTIONS INC

company

SEC Filings & Insider Trading Activity 2026

Risk Factors

• • New accounting standards ASU 2025-07, ASU 2025-06, ASU 2025-05, ASU 2025-04, ASU 2025-03 issued by FASB, effective 2026-2028, no expected material impact stated
• • Material update: April 2025 acquisition of PanTHERA, $15.5M in-process R&D cost expensed immediately due to no alternative future use

What are the latest BLFS SEC filings in 2026?

BIOLIFE SOLUTIONS INC (BLFS) has filed a 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 6, 2025, an 8-K current report on March 2, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did BLFS file its most recent 10-K annual report?

BIOLIFE SOLUTIONS INC (BLFS) filed its most recent 10-K annual report on February 26, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view BLFS 10-Q quarterly reports?

BIOLIFE SOLUTIONS INC (BLFS)'s most recent 10-Q quarterly report was filed on November 6, 2025. SignalX displays every BLFS 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has BLFS filed recently?

BIOLIFE SOLUTIONS INC (BLFS)'s most recent 8-K was filed on March 2, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find BLFS insider trading activity (Form 4)?

SignalX aggregates every BLFS Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does BLFS file with the SEC?

BIOLIFE SOLUTIONS INC (BLFS) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new BLFS filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for BIOLIFE SOLUTIONS INC (BLFS).

What is BLFS's SEC CIK number?

BIOLIFE SOLUTIONS INC (BLFS)'s SEC CIK (Central Index Key) number is 834365. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 834365 to look up all BLFS filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find BLFS return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from BIOLIFE SOLUTIONS INC (BLFS) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.